Activity Title: Early MS: Induction Therapy and Escalation Strategies
Topic: Multiple Sclerosis
Accreditation Type: AMA PRA Category 1 Credit(s)™/ANCC Credits
Release Date: 7/31/17
Expiration Date: 7/30/18 – This activity is no longer available for CME/CE
Estimated Time to Complete Activity: 30 minutes

LEARNING OBJECTIVES
Upon completion of the activity, participants should be able to:

• Analyze data from clinical trials of disease modifying therapies to inform personalized treatment and monitoring of outcomes for patients with MS
• Access reliable and evidence-based resources in order to stay current with advances in the management of MS

FACULTY
Stephen Krieger, MD
Associate Professor of Neurology
Icahn School of Medicine at Mount Sinai

METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT
Technical Requirements: http://www.francefoundation.com/general-requirements.html

1. There are no fees for participating in and receiving credit for this activity.
2. Review the activity objectives and CME/CE information.
3. Complete the CME/CE activity
4. Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
5. Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
6. Your CME/CE certificate will be available for download

ACCREDITED PROVIDER
This activity is jointly provided by CMSC and NPA in collaboration with The France Foundation.

TARGET AUDIENCE
This educational initiative is intended to meet the needs of neurologists, nurses, nurse practitioners, physician assistants, rehabilitation professionals, case managers, mental health professionals, social workers and others involved in the management of patients with MS.

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Consortium of Multiple Sclerosis Centers (CMSC) and Nurse Practitioner Alternatives (NPA) in collaboration with The France Foundation. The Consortium of Multiple Sclerosis Centers is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION
PHYSICIANS
The CMSC designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES
Nurse Practitioner Alternatives (NPA) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
NPA designates this enduring activity for a maximum of 0.5 Continuing Nursing Education Credits.

DISCLOSURE POLICY
In accordance with the ACCME Standards for Commercial Support, the Consortium of Multiple Sclerosis Centers (CMSC), Nurse Practitioner Alternatives (NPA), and The France Foundation (TFF) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. CMSC, NPA, and TFF resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, CMSC, NPA, and TFF seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. CMSC, NPA, and TFF are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Activity Staff Disclosures
The planners, reviewers, editors, staff, or other members at CMSC who control content have disclosed no relevant financial relationships.

Laurie Scudder, DNP, NP, has served as Nurse Planner for this activity. She has declared that she has no relevant financial relationships.

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have disclosed no relevant financial relationships.

Faculty Disclosures - Content Creators
The following faculty report that they have relevant financial relationships to disclose:

• Stephen Krieger, MD, has served as a consultant for Acorda, Bayer, Biogen, EMD Serono, Genentech, Genzyme, Novartis, and Teva. He has also served on the speakers bureau for Biogen and Genentech, and was a committee member for MedDay.

DISCLOSURE OF UNLABELED USE
CMSC, NPA, and TFF require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. CMSC, NPA, and TFF do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

COMMERCIAL SUPPORT ACKNOWLEDGMENT
This activity is supported by educational grants received from Biogen and Sanofi Genzyme.

DISCLAIMER
CMSC, NPA, and TFF present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. CMSC, NPA, TFF, and the commercial supporters assume no liability for the information herein.

COPYRIGHT INFORMATION
Copyright © 2017 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.

Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.

PRIVACY POLICY
The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

Additional information regarding The France Foundation’s Privacy Policy can be viewed at https://www.francefoundation.com/privacy.

CONTACT INFORMATION
If you have questions about this CME/CE activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.